Researchers Develop Methods to Separate Hallucinogenic Effects from Therapeutic Benefits of Psychedelics

Researchers have reported progress in separating the hallucinogenic effects of psychedelics from their potential therapeutic benefits. This development is part of a broader effort to harness the medicinal properties of these compounds while minimizing side effects. The findings were highlighted alongside other scientific advancements, including spatiotemporal degraders, LIMCH1 vesicles in preeclampsia, and updates on three new biotechnology companies.

The study aims to address concerns surrounding the use of psychedelics in medical treatments by focusing on their non-hallucinogenic properties. Scientists are exploring ways to retain the therapeutic impact of these substances without inducing altered states of perception. In addition to this research, recent discoveries include spatiotemporal degraders that target specific proteins for degradation at precise times and locations within cells, as well as insights into LIMCH1 vesicles’ role in preeclampsia, a pregnancy-related condition. Updates on three emerging biotech companies also featured prominently in this week’s scientific roundup.

Newsflash | Powered by GeneOnline AI

Source: GO-AI-ne1

For any suggestion and feedback, please contact us.

Date: February 4, 2026

Author

GOAI